Abbott Reports Q1 2026 Earnings Results
Abbott (ABT) reported Q1 2026 earnings with adjusted EPS of $1.15, a 6% increase year-over-year, and total sales growth of 3.7% on a comparable basis. The company raised its full-year sales growth outlook to 6.5%-7.5% and revised its adjusted EPS guidance midpoint to $5.48, reflecting dilution from the Exact Sciences acquisition.
Topics: Acquisition Impact Earnings EPS Guidance Sales Growth Segment Performance